Sax PE - Search Results

1

The survival benefits of AIDS treatment in the United States.

Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. Walensky RP, et al. Among authors: sax pe. J Infect Dis. 2006 Jul 1;194(1):11-9. doi: 10.1086/505147. Epub 2006 Jun 1. J Infect Dis. 2006. PMID: 16741877

2

Potential clinical implications of interlaboratory variability in CD4+ T-lymphocyte counts of patients infected with human immunodeficiency virus.

Sax PE, Boswell SL, White-Guthro M, Hirsch MS. Sax PE, et al. Clin Infect Dis. 1995 Nov;21(5):1121-5. doi: 10.1093/clinids/21.5.1121. Clin Infect Dis. 1995. PMID: 8589131

3

Adjunctive corticosteroid therapy for patients whose treatment for disseminated Mycobacterium avium complex infection has failed.

Dorman SE, Heller HM, Basgoz NO, Sax PE. Dorman SE, et al. Among authors: sax pe. Clin Infect Dis. 1998 Mar;26(3):682-6. doi: 10.1086/514597. Clin Infect Dis. 1998. PMID: 9524844

4

Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy.

Merrill DP, Martinez-Picado J, Tremblay C, Sax PE, Boswell SL, Wong JT, D'Aquila RT, Walker BD, Hirsch MS. Merrill DP, et al. Among authors: sax pe. J Infect Dis. 1999 Feb;179(2):345-51. doi: 10.1086/314591. J Infect Dis. 1999. PMID: 9878017 Clinical Trial.

5

Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection.

Vidrih JA, Walensky RP, Sax PE, Freedberg KA. Vidrih JA, et al. Among authors: sax pe. Am J Med. 2001 Aug 15;111(3):192-4. doi: 10.1016/s0002-9343(01)00804-x. Am J Med. 2001. PMID: 11530029

6

Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy.

Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Islam R, Freedberg KA. Walensky RP, et al. Among authors: sax pe. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):27-37. doi: 10.1097/00126334-200209010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12352147

7

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.

Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ. Schackman BR, et al. Among authors: sax pe. Arch Intern Med. 2002 Nov 25;162(21):2478-86. doi: 10.1001/archinte.162.21.2478. Arch Intern Med. 2002. PMID: 12437408

8

Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution.

Hadigan C, Meigs JB, Wilson PW, D'Agostino RB, Davis B, Basgoz N, Sax PE, Grinspoon S. Hadigan C, et al. Among authors: sax pe. Clin Infect Dis. 2003 Apr 1;36(7):909-16. doi: 10.1086/368185. Epub 2003 Mar 20. Clin Infect Dis. 2003. PMID: 12652392

9

Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.

Gandhi RT, Wurcel A, Lee H, McGovern B, Boczanowski M, Gerwin R, Corcoran CP, Szczepiorkowski Z, Toner S, Cohen DE, Sax PE, Ukomadu C. Gandhi RT, et al. Among authors: sax pe. Clin Infect Dis. 2003 Jun 15;36(12):1602-5. doi: 10.1086/375084. Epub 2003 Jun 6. Clin Infect Dis. 2003. PMID: 12802762

10

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.

Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR 3rd, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Goldie SJ, et al. Among authors: sax pe. Am J Med. 2003 Dec 1;115(8):632-41. doi: 10.1016/j.amjmed.2003.07.007. Am J Med. 2003. PMID: 14656616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters